Global Menopause Market by Treatment (Dietary Supplements, OTC Pharma Products), Product Type (Gel, Injection, Oral Dosage), Indication, Distribution Challenge - Forecast 2024-2030- Product Image

Sale

Global Menopause Market by Treatment (Dietary Supplements, OTC Pharma Products), Product Type (Gel, Injection, Oral Dosage), Indication, Distribution Challenge - Forecast 2024-2030

Report
193 Pages
March 2024
Region: Global
360iResearch™
ID: 5454968

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The Menopause Market size was estimated at USD 17.79 billion in 2023, USD 18.99 billion in 2024, and is expected to grow at a CAGR of 6.85% to reach USD 28.29 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Menopause Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Menopause Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Menopause Market, highlighting leading vendors and their innovative profiles. These include Abbvie Inc., Apotex Inc., Astellas Pharma Inc., Bayer AG, Cipla Inc., Eli Lilly and Company, Fervent Pharmaceuticals, LLC, GlaxoSmithKline plc, Glenmark Pharmaceuticals Ltd., Merck & Co.Inc., Mithra Pharmaceuticals, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and TherapeuticsMD Inc.

Market Segmentation & Coverage

This research report categorizes the Menopause Market to forecast the revenues and analyze trends in each of the following sub-markets:

Treatment
- Dietary Supplements
- OTC Pharma Products
  - Hormonal products
    - Combination Estrogen and Other Medicines
    - Combination Estrogen and Progestin Medicines
    - Estrogen-Only Medicines
    - Progestin-Only Medicines
  - Non-hormonal products
Product Type
- Gel
- Injection
- Oral Dosage
- Patch
- Pill
- Powder
- Skin Cream
- Skin Spray (Transdermal)
- Vaginal Cream
- Vaginal Ring
Indication
- Dry Eyes
- Dry Skin
- Hot Flashes
- Mood Swings, Mild depression & Irritability
- Night Sweats and Cold Flashes.
- Osteoporosis
- Trouble Sleeping
- Urinary Urgency
- Vaginal Dryness
Distribution Challenge
- Hospital Pharmacies
- Online Stores
- Retail Pharmacies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Menopause Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Menopause Market?
What are the technology trends and regulatory frameworks in the Menopause Market?
What is the market share of the leading vendors in the Menopause Market?
Which modes and strategic moves are suitable for entering the Menopause Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Menopause Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High prevalence of vasomotor and other menopausal symptoms
5.1.1.2. Rising awareness regarding menopause health
5.1.1.3. Increasing number of new drug approvals for the treatment
5.1.2. Restraints
5.1.2.1. Side effects associated with hormonal products and the availability of generic medicines
5.1.3. Opportunities
5.1.3.1. Prevalence of herbal treatment for menopause
5.1.3.2. Increasing research supporting the advantages of dietary supplements
5.1.4. Challenges
5.1.4.1. Lack of advanced healthcare infrastructure in developing nations
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Menopause Market, by Treatment

6.1. Introduction
6.2. Dietary Supplements
6.3. OTC Pharma Products
6.4.1. Hormonal products
6.4.2.1. Combination Estrogen and Other Medicines
6.4.2.2. Combination Estrogen and Progestin Medicines
6.4.2.3. Estrogen-Only Medicines
6.4.2.4. Progestin-Only Medicines
6.4.2. Non-hormonal products

7. Menopause Market, by Product Type

7.1. Introduction
7.2. Gel
7.3. Injection
7.4. Oral Dosage
7.5. Patch
7.6. Pill
7.7. Powder
7.8. Skin Cream
7.9. Skin Spray (Transdermal)
7.10. Vaginal Cream
7.11. Vaginal Ring

8. Menopause Market, by Indication

8.1. Introduction
8.2. Dry Eyes
8.3. Dry Skin
8.4. Hot Flashes
8.5. Mood Swings, Mild depression & Irritability
8.6. Night Sweats and Cold Flashes.
8.7. Osteoporosis
8.8. Trouble Sleeping
8.9. Urinary Urgency
8.10. Vaginal Dryness

9. Menopause Market, by Distribution Challenge

9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Stores
9.4. Retail Pharmacies

10. Americas Menopause Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Menopause Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Menopause Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Abbvie Inc.
14.1.2. Apotex Inc.
14.1.3. Astellas Pharma Inc.
14.1.4. Bayer AG
14.1.5. Cipla Inc.
14.1.6. Eli Lilly and Company
14.1.7. Fervent Pharmaceuticals, LLC
14.1.8. GlaxoSmithKline plc
14.1.9. Glenmark Pharmaceuticals Ltd.
14.1.10. Merck & Co.Inc.
14.1.11. Mithra Pharmaceuticals
14.1.12. Novartis AG
14.1.13. Pfizer Inc.
14.1.14. Teva Pharmaceutical Industries Ltd.
14.1.15. TherapeuticsMD Inc.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. MENOPAUSE MARKET RESEARCH PROCESS
FIGURE 2. MENOPAUSE MARKET SIZE, 2023 VS 2030
FIGURE 3. MENOPAUSE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MENOPAUSE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. MENOPAUSE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. MENOPAUSE MARKET DYNAMICS
FIGURE 7. MENOPAUSE MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 8. MENOPAUSE MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 10. MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. MENOPAUSE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. MENOPAUSE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2023 VS 2030 (%)
FIGURE 14. MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. MENOPAUSE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. MENOPAUSE MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. MENOPAUSE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. MENOPAUSE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MENOPAUSE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 6. MENOPAUSE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 9. MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 11. MENOPAUSE MARKET SIZE, BY COMBINATION ESTROGEN AND OTHER MEDICINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. MENOPAUSE MARKET SIZE, BY COMBINATION ESTROGEN AND PROGESTIN MEDICINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. MENOPAUSE MARKET SIZE, BY ESTROGEN-ONLY MEDICINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. MENOPAUSE MARKET SIZE, BY PROGESTIN-ONLY MEDICINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. MENOPAUSE MARKET SIZE, BY NON-HORMONAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 17. MENOPAUSE MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. MENOPAUSE MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. MENOPAUSE MARKET SIZE, BY ORAL DOSAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. MENOPAUSE MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. MENOPAUSE MARKET SIZE, BY PILL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. MENOPAUSE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. MENOPAUSE MARKET SIZE, BY SKIN CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. MENOPAUSE MARKET SIZE, BY SKIN SPRAY (TRANSDERMAL), BY REGION, 2018-2030 (USD MILLION)
TABLE 25. MENOPAUSE MARKET SIZE, BY VAGINAL CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. MENOPAUSE MARKET SIZE, BY VAGINAL RING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 28. MENOPAUSE MARKET SIZE, BY DRY EYES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. MENOPAUSE MARKET SIZE, BY DRY SKIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. MENOPAUSE MARKET SIZE, BY HOT FLASHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. MENOPAUSE MARKET SIZE, BY MOOD SWINGS, MILD DEPRESSION & IRRITABILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. MENOPAUSE MARKET SIZE, BY NIGHT SWEATS AND COLD FLASHES., BY REGION, 2018-2030 (USD MILLION)
TABLE 33. MENOPAUSE MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. MENOPAUSE MARKET SIZE, BY TROUBLE SLEEPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. MENOPAUSE MARKET SIZE, BY URINARY URGENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. MENOPAUSE MARKET SIZE, BY VAGINAL DRYNESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 38. MENOPAUSE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. MENOPAUSE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. MENOPAUSE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 60. CANADA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. CANADA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 62. CANADA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 63. CANADA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. CANADA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. CANADA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 66. MEXICO MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 67. MEXICO MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 68. MEXICO MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 69. MEXICO MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. MEXICO MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 71. MEXICO MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 92. CHINA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 93. CHINA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 94. CHINA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 95. CHINA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. CHINA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 97. CHINA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 98. INDIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 99. INDIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 100. INDIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 101. INDIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. INDIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. INDIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 104. INDONESIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 105. INDONESIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 106. INDONESIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 110. JAPAN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 111. JAPAN MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 112. JAPAN MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 113. JAPAN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. JAPAN MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. JAPAN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 116. MALAYSIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 117. MALAYSIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 118. MALAYSIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 119. MALAYSIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. MALAYSIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 121. MALAYSIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 122. PHILIPPINES MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 123. PHILIPPINES MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 124. PHILIPPINES MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 125. PHILIPPINES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. PHILIPPINES MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 127. PHILIPPINES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 128. SINGAPORE MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 129. SINGAPORE MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 130. SINGAPORE MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 131. SINGAPORE MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. SINGAPORE MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 133. SINGAPORE MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 134. SOUTH KOREA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 135. SOUTH KOREA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 136. SOUTH KOREA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 137. SOUTH KOREA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. SOUTH KOREA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. SOUTH KOREA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 140. TAIWAN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 141. TAIWAN MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 142. TAIWAN MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 143. TAIWAN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. TAIWAN MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 145. TAIWAN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 146. THAILAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 147. THAILAND MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 148. THAILAND MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 149. THAILAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. THAILAND MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 151. THAILAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 152. VIETNAM MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 153. VIETNAM MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 154. VIETNAM MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 155. VIETNAM MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. VIETNAM MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 157. VIETNAM MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 165. DENMARK MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 166. DENMARK MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 167. DENMARK MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 168. DENMARK MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. DENMARK MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 170. DENMARK MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 171. EGYPT MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 172. EGYPT MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 173. EGYPT MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 174. EGYPT MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. EGYPT MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 176. EGYPT MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 177. FINLAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 178. FINLAND MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 179. FINLAND MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 180. FINLAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. FINLAND MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 182. FINLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 183. FRANCE MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 184. FRANCE MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 185. FRANCE MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 186. FRANCE MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. FRANCE MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 188. FRANCE MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 189. GERMANY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 190. GERMANY MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 191. GERMANY MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 192. GERMANY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. GERMANY MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 194. GERMANY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 195. ISRAEL MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 196. ISRAEL MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 197. ISRAEL MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 198. ISRAEL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. ISRAEL MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 200. ISRAEL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 201. ITALY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 202. ITALY MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 203. ITALY MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 204. ITALY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. ITALY MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 206. ITALY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 218. NIGERIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 219. NORWAY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 220. NORWAY MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 221. NORWAY MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 222. NORWAY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. NORWAY MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 224. NORWAY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 225. POLAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 226. POLAND MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 227. POLAND MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 228. POLAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. POLAND MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 230. POLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 231. QATAR MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 232. QATAR MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 233. QATAR MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 234. QATAR MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. QATAR MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 236. QATAR MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 240. RUSSIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 241. RUSSIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 242. RUSSIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 252. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 255. SPAIN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 256. SPAIN MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 257. SPAIN MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 258. SPAIN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. SPAIN MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 260. SPAIN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 261. SWEDEN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 262. SWEDEN MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 263. SWEDEN MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 264. SWEDEN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 265. SWEDEN MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 266. SWEDEN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 268. SWITZERLAND MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 269. SWITZERLAND MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 270. SWITZERLAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. SWITZERLAND MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 272. SWITZERLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 273. TURKEY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 274. TURKEY MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 275. TURKEY MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 276. TURKEY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. TURKEY MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 278. TURKEY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 286. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 288. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 290. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
TABLE 291. MENOPAUSE MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 292. MENOPAUSE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 293. MENOPAUSE MARKET LICENSE & PRICING

Companies Mentioned

Abbvie Inc.
Apotex Inc.
Astellas Pharma Inc.
Bayer AG
Cipla Inc.
Eli Lilly and Company
Fervent Pharmaceuticals, LLC
GlaxoSmithKline plc
Glenmark Pharmaceuticals Ltd.
Merck & Co.Inc.
Mithra Pharmaceuticals
Novartis AG
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
TherapeuticsMD Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	193
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 18.99 Billion
Forecasted Market Value ( USD ) by 2030	$ 28.29 Billion
Compound Annual Growth Rate	6.8%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,802GBP €3624EUR$3,749USD£3,113GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,549GBP €4591EUR$4,749USD£3,944GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,297GBP €5558EUR$5,749USD£4,774GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,044GBP €6525EUR$6,749USD£5,605GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7613EUR$7,874USD£6,539GBP €8458EUR$8,749USD£7,265GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Menopause Market Size, Share & Trends Analysis Report by Treatment (Dietary Supplements, OTC Pharma Products), Region (North America, Europe, Latin America), and Segment Forecasts, 2024-2030

Menopause - Market Insights, Epidemiology and Market Forecast - 2032

Menopause Market Report 2023-2033

Menopause Global Market Report 2024

Vasomotor Symptoms of Menopause - Pipeline Insight, 2024